Privium Fund Management (UK)’s Protara Therapeutics TARA Stock Holding History

Privium Fund Management (UK)’s Portfolio TARA Stock Details TARA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-114,708	Closed	-$233K	–	132
2024 Q2	$233K	Sell	114,708 -5,022	-4%	-$14.7K	0.09%	144
2024 Q1	$496K	Hold	119,730	–	–	0.25%	60
2023 Q4	$225K	Hold	119,730	–	–	0.15%	66
2023 Q3	$201K	Hold	119,730	–	–	0.16%	65
2023 Q2	$272K	Hold	119,730	–	–	0.21%	57
2023 Q1	$401K	Hold	119,730	–	–	0.32%	51
2022 Q4	$321K	Buy	119,730 +84,730	+242%	+$267K	0.24%	41
2022 Q3	$104K	Buy	+35,000	New	+$119K	0.13%	50

Other funds holding TARA

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Stempoint Capital New York $520M AUM 281.95% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return